Quest Diagnostics (DGX) Net Margin (2009 - 2026)

Quest Diagnostics has disclosed Net Margin across 18 years of filings, most recently posting 1.38% for Q1 2026.

• Net Margin for Q1 2026 came in at 1.38%, down 832.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.65% (down 203.0% YoY), and the FY2025 annual result was 8.77%, down 1.0% from the prior year.
• Net Margin came in at 1.38% for Q1 2026 at Quest Diagnostics, down from 7.59% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 11.64% in Q1 2022 to a low of 1.38% in Q1 2026.
• The 5-year median for Net Margin is 7.6% (2025), against an average of 7.35%.
• Across the five-year window, Net Margin tumbled 1984 bps in 2022 and surged 382 bps in 2023, its largest moves.
• Quest Diagnostics' Net Margin stood at 3.26% in 2022, then soared by 117 bps to 7.08% in 2023, then advanced by 6 bps to 7.48% in 2024, then gained by 2 bps to 7.59% in 2025, then tumbled by 118 bps to 1.38% in 2026.
• The last three Net Margin figures came in at 1.38% (Q1 2026), 7.59% (Q4 2025), and 7.6% (Q3 2025), per Business Quant data.